TITLE

A shot in the arm for shock to the heart

AUTHOR(S)
Kent, Heather
PUB. DATE
January 2000
SOURCE
CMAJ: Canadian Medical Association Journal;1/11/2000, Vol. 162 Issue 1, p99
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on a study published in a 1999 issue of `New England Journal of Medicine' on the impact of immediate angioplasty or bypass surgery on long-term chances of survival in heart attack patients with cardiogenic shock. Role of physicians at Vancouver, British Columbia's St. Paul's Hospital; Details of the international study; Reduction in mortality rate.
ACCESSION #
2697812

 

Related Articles

  • Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. Thiele, Holger; Zeymer, Uwe; Neumann, Franz-Josef; Ferenc, Miroslaw; Olbrich, Hans-Georg; Hausleiter, J�rg; Richardt, Gert; Hennersdorf, Marcus; Empen, Klaus; Fuernau, Georg; Desch, Steffen; Eitel, Ingo; Hambrecht, Rainer; Fuhrmann, J�rg; B�hm, Michael; Ebelt, Henning; Schneider, Steffen; Schuler, Gerhard; Werdan, Karl // New England Journal of Medicine;10/4/2012, Vol. 367 Issue 14, p1287 

    Background: In current international guidelines, intraaortic balloon counterpulsation is considered to be a class I treatment for cardiogenic shock complicating acute myocardial infarction. However, evidence is based mainly on registry data, and there is a paucity of randomized clinical trials....

  • Delays in Transfer For Primary PCI in STEMI. Boyle, Andrew J. // Clinical Cardiology Alert;Dec2011, Vol. 30 Issue 12, p89 

    The author discusses a study by M. Miedema and colleagues, which examined patients with ST-elevation myocardial infarction (STEMI) transferred for percutaneous coronary intervention (PCI) for causes of delay in transfer and the clinical outcomes associated with delays. The study showed that...

  • PREDICTORS OF PROGNOSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. Vaz, F. S.; Ferreira, A. M.; Kulkarni, M. S.; Perni, S. G.; Pinto, N. R.; Motghare, D. D.; Dsouza, L. C. // International Journal of Science & Nature;2013, Vol. 4 Issue 2, p284 

    The determinants of prognosis in patients with acute myocardial infarction at a tertiary care hospital were studied. Demographic and risk variables were explored in the outcome (survived or died) of AMI patients during hospital treatment. Bivariate analysis was performed and unadjusted odds...

  • Adherencia a guías de infarto agudo de miocardio con elevación de segmento ST en un Hospital Universitario de nivel IV en Bogotá, Colombia, en periodos comprendidos entre enero de 2008 y julio de 2011. MOSQUERA KLINGER, GABRIEL ALONSO; ALBERTO GARCÍA, ÁNGEL; BOHÓRQUEZ RODRÍGUEZ, RICARDO; MUÑOZ VELANDIA, ÓSCAR // Universitas Médica;ene-mar2015, Vol. 56 Issue 1, p20 

    Introduction: The ST Segment Elevation Myocardial Infarction (STEMI) is associated with high morbidity and mortality, identifying disease early, and adherence to management guidelines have impacted clinical outcomes in this entity. Objectives: To evaluate adherence to guidelines in the...

  • Recent trends in mortality from and incidence of myocardial infarction in Stockholm.  // British Medical Journal (Clinical Research Edition);3/7/1987, Vol. 294 Issue 6572, p609 

    Presents the mortality trends of the myocardial infarction cases in Stockholm, Sweden. Statistics of the declined mortality; Estimate of persons in risk; Assessment of the diagnostic practice and accuracy of the medical information systems.

  • Research. Greene, Jan; Serb, Chris // H&HN: Hospitals & Health Networks;04/05/97, Vol. 71 Issue 7, p25 

    Provides information on the facility set up by the National Institutes of Health (NIH) for analyzing common disorders caused by multiple genes and on the United States patient's survival from shock after a heart attack. Eight NIH components; Population of heart attack patients in 15 countries;...

  • REGENERX COMPLETES ENROLLMENT OF PHASE IA FOR HEART DRUG.  // Biotech Business;Aug2008, Vol. 21 Issue 8, p7 

    The article reports on the completion of enrollment and dosing of subjects for Phase IA clinical trial testing RGN-352 of RegeneRx Biopharmaceuticals in 2008. The company aims to study the potential of the injectable formulation to use in treating acute myocardial infarction patients. The trial...

  • Vasodilators.  // Cardiovascular Pharmacology Manual;2008, p5 

    The article presents information about several vasodilators, they include nitroglycerin and nitroprusside. Some of the diseases treated by these vasolidators are hypertensive crisis, myocardial infarction and cardiogenic shock. Their adverse events include headache, dizziness, tachycardia and...

  • Therapeutic Strategies for Hemodynamic and Circulatory Support after PCI. Mosely, Mary // MD Conference Express;Aug2013, Vol. 13 Issue 7, p32 

    Treatment strategies for ST-segment elevation myocardial infarction (STEMI) utilize both pharmacological therapies and devices designed to restore coronary blood flow. While these therapies are generally effective, a proportion of patients with STEMI will develop cardiogenic shock, one of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics